English | Español
Patient Daily | Feb 11, 2026

BioNTech expands cancer pipeline while Moderna faces setbacks with mRNA-only strategy
Patient Daily | Feb 11, 2026

Novo Nordisk reports new data showing CagriSema outperforms Wegovy on blood sugar control
Patient Daily | Feb 11, 2026

Pfizer reports early obesity drug results; analysts seek more data
Patient Daily | Feb 11, 2026

Novo Nordisk forecasts sales decline amid U.S. drug price pressures
Patient Daily | Feb 11, 2026

Daiichi Sankyo ends DS-9606 cancer drug program amid pipeline setbacks
Patient Daily | Feb 11, 2026

Merck highlights pipeline expansion amid questions over future growth
Patient Daily | Feb 11, 2026

Pfizer reports over 12% weight loss with new obesity drug candidate after Metsera acquisition
Patient Daily | Feb 11, 2026

Emphasizing strengths helps boost confidence and goal achievement in people with depression

Trending
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+ Regulatory
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'
Patient Daily | Apr 8, 2026

Breathe Free Teams Pack Meals at Community Volunteer Event, Expanding Care Beyond Clinics